Integral Diagnostics | IDX - Stammkapital

Aktienkurs
2.27
Täglich Wechseln
0 0%
Monatlich
-3.81%
Jährlich
0.44%
Q2 Prognose
2.20




Stammkapital Veränderung Datum
Alcidion AUD 1.34B 0 2025-12
Ansell USD 142.94M 885.26M 2025-12
Cochlear AUD 65.4M 1.12B 2025-12
CSL USD 482.13M 93.87M 2025-12
Healius AUD 2.6B 100K 2024-12
Mayne Pharma AUD 81.25M 0 2025-06
Monash IVF AUD 389.63M 117.15M 2025-12
Nanosonics AUD 303.35M 188.61M 2025-12
Polynovo AUD 690.84M 991 2025-12
Ramsay Health Care AUD 229.93M 29.81K 2025-12
ResMed USD 145.66M 279.42K 2025-12
Sigma Healthcare AUD 11.5B 9.93B 2025-12
Sonic Healthcare AUD 4.15B 467K 2024-12
Telix Pharmaceuticals AUD 338.78M 379K 2025-12